logo
  

Novartis Announces AIN457 Phase II Data - Quick Facts

Novartis (NVS) announced new Phase II data showing AIN457, or secukinumab, may significantly improve moderate-to-severe plaque psoriasis on the hands, feet and nails when used every week for the first month of treatment, compared to placebo. Additional analysis on patients with moderate-to-severe plaque psoriasis also showed that AIN457 may successfully improve quality of life by Week 12 in the study. The results will be presented on Sept. 27 at the European Academy of Dermatology and Venereology 21st Congress, in Prague, Czech Republic.

The study safety analysis of the data showed a comparable safety profile between treatment and placebo, with the most common adverse events observed being infections.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
King's Hawaiian is recalling its Pretzel Slider Buns, Pretzel Hamburger Buns and Pretzel Bites products as they contain one ingredient already recalled by Lyons Magnus, the U.S. Food And Drug Administration said. The Pretzel recall was initiated out of an abundance of caution after one of its supplier Lyons Magnus recently called back various nutritional and beverage products. German consumer goods maker Henkel AG & Co. reported Monday weak profit in its first half amid increasing costs, despite growth in sales. Further, the company maintained its adjusted earnings forecast for fiscal 2022, but raised outlook for organic sales growth.For fiscal 2022, the company continues to expect adjusted earnings per preferred share to decline in the range of 15 percent to 35 percent Woodbridge, Illinois-based Home Run Inn Frozen Foods is recalling around 13,099 pounds of frozen meat pizza products, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The agency warned that the products may be contaminated with extraneous materials, specifically metal.
Follow RTT